Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 511 clinical trials
Featured trial
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

216 weeks of treatment (A45 Trial) and to determine whether treatment with BAN2401 is superior to placebo in reducing brain amyloid accumulation as measured by amyloid positron emission tomography

dementia
amyloid
mental state examination
mini-mental state examination
  • 44 views
  • 18 Jul, 2023
  • 5 locations
Featured trial
Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD)

The main purpose of this study is to examine the efficacy and safety of a repeated dosing ketamine infusion paradigm compared to placebo in individuals with PD. A subset of participants in each arm will undergo baseline and post-treatment PET and fMRI scans, to examine whether changes in synaptic density …

depression
depressed mood
hoehn and yahr scale
depressive disorder
ketamine
  • 46 views
  • 07 Oct, 2022
  • 1 location
Featured trial
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma(CLL/SLL), Lymphoplasmacytic Lymphoma(LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma(SMZL)

drawn. When required patients may undergo additional testing that may include bone marrow biopsy and aspiration, blood drawing, lymph node biopsy, x-ray studies, positron emission tomography and CT and

lymphocytosis
cancer
marginal zone lymphoma
lymphoma
chronic lymphocytic leukemia
  • 115 views
  • 15 Apr, 2019
  • 1 location
Featured trial
A PHASE III, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF ALZHEIMER’S DISEASE

This study is designed to evaluate the efficacy and safety of Gantenerumab in participants at risk for or at the earliest stages of Alzheimer’s Disease (AD) 

Accepts healthy volunteers
  • 4 views
  • 24 Jun, 2022
  • 1 location
Featured trial
Cardiovascular Disease Discovery Protocol

>Positron emission tomography (PET) imaging to study possible fat infiltration of the heart Six-minute walk test to study heart, lung, and muscle function and performance Vascular ultrasound

angiography
  • 613 views
  • 08 Apr, 2019
  • 1 location
Featured trial
Participants Needed: Brain Imaging Research Study on Alzheimer’s Disease and Mild Cognitive Impairment

Participants diagnosed with Alzheimer’s Disease (AD) or Mild Cognitive Impairment (MCI) will receive an amyloid PET scan to help confirm AD diagnosis, as well as other noninvasive brain imaging (MEG and MRI) and cognitive assessments. The goals of this study are to determine how AD and MCI affect brain activity …

Accepts healthy volunteers
  • 6 views
  • 18 Jul, 2023
  • 1 location
Featured trial
Longitudinal Investigation of I2BS in PD (FOX_2)

In this study, the researchers aim to find a biomarker of PD. Using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic

dopamine transporter
SPECT Scan
positron emission tomography
dexmedetomidine
dopamine
  • 4 views
  • 16 Mar, 2023
  • 1 location
Featured trial
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR

performing two Positron Emission Tomography (PET) scans using the tracer [11C]PBR28, that takes pictures of the brain highlighting the areas of inflammation, before and after the administration of a compound

depression
movement disorder
parkinson's disease
neuropsychological assessment
Accepts healthy volunteers
  • 0 views
  • 17 Mar, 2023
  • 1 location
PSMA-PET Registry for Recurrent Prostate Cancer (PREP)

This study aims to institute a province-wide registry leveraging the availability of a new Positron Emission Tomography tracer, [18F]-DCFPyL and PET expertise across Ontario centers to improve

ct scan
bone scan
positron emission tomography
karnofsky performance status
prostatectomy
  • 108 views
  • 04 Apr, 2023
  • 6 locations
A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP). (FALKON)

years of age or older are also eligible for a sub study to evaluate HO lesions assessed by another type of scan, Fluorine-18-labelled natrium fluoride Positron Emission Tomography-Computed Tomography

  • 0 views
  • 01 Oct, 2023
  • 20 locations